Klin Farmakol Farm. 2011;25(4):177-183

Allergic rhinitis: clinical aspects and treatment

Irena Krčmová
Ústav klinické imunologie a alergologie FN, Hradec Králové

Allergic rhinitis is among the most common allergic diseases and has been estimated to affect 15-30% of the population. Although rhinitis

was once considered to be a medical condition of trivial importance, now it is recognized to affect the quality of life and impair physical

and cognitive functioning. Allergic rhinitis should be considered as a possible concomitant diagnosis in all patients with bronchial asthma,

recurrent otitis, chronic sinusitis and nasal polyposis. The same inflammatory mechanisms and inflammatory cells are present in nasal and

bronchial mucosa. Appropriate anti-inflammatory therapy as an important step in the treatment reduces eosinophilic inflammation.

Keywords: allergic rhinitis, allergens, eosinophilic inflammation, therapy

Published: December 18, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Krčmová I. Allergic rhinitis: clinical aspects and treatment. Klin Farmakol Farm. 2011;25(4):177-183.
Download citation

References

  1. Blaiss MS. Cognitive, social, and economic costs of allergic rhinitis. Allergy Asthma Proc 2000; 21: 7-13. Go to original source... Go to PubMed...
  2. Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the Health Organization, GA (2)LEN and AllerGen). Allergy 2008; 63(Suppl 86): 8-160. Go to original source... Go to PubMed...
  3. Braunstahl G-J, Fokkens WJ. Nasal involvement in allergic astma. Allergy 2003; 58: 1235-1243. Go to original source... Go to PubMed...
  4. Braunstahl G-J, Fokkens WJ, Overbeek SE, KleinJan A, Hoogsteden HC, Prins J-B. Mucosal and systemic inflammatory changes in allergic rhinitis and asthma: a comparison between upper and lower airways. Allergy 2003; 33: 579-587. Go to original source... Go to PubMed...
  5. Hellgren J, Torén K, Balder B, Palmqvist M, Löwhagen O, and Karlsson G. Increased nasal mucosal swelling in subjects with asthma, Clin and Exp Allergy 2002; 32: 64-69. Go to original source... Go to PubMed...
  6. Bousquet J, et al. Allergic Rhinitis and its Impact on asthma (pocket Guide), J All Clin Immunol 2001; 108(Suppl 5): 153. Go to original source... Go to PubMed...
  7. Cauwenberge P, et al. Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology, Allergy; 55(2): 116-34.
  8. Alkis T. Rhinitis and asthma: Evidence for respiratory systém integration. J Allergy Clin Immunol 2003; 6: 1171-1179. Go to original source...
  9. Skoner DP. Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis. J Allergy Clin Immunol 2001; 108: S2-S8. Go to original source... Go to PubMed...
  10. Špičák V, Kašák V, Pohunek P. Globální strategie péče o astma a jeho prevenci. 1. vyd. Praha: Jalna, 2003.
  11. Vignola AM, Chanez P, Bousquet J. The relationship between asthma and allergic rhinitis: exploring the basis for a common pathophysiology. Allergy Rev 2003; 3: 63-68. Go to original source...
  12. Jaegger S. Exposure to grass pollen in Europe. Clin Exp Allergy Rev 2008; 8: 2-6. Go to original source...
  13. Seberová E. Chronická rýma a astma. Alergie 2001; 2: 24-30.
  14. Corren J. The link between allergic rhinitis and asthma, otitis media, sinusitis, and nasal polyps. Rhinitis 2000; 2: 445-460. Go to original source...
  15. Špičák V, Petrů V. Století specifické alergenové imunotepapie 1911-2011. Alergie 2011; 13(Suppl 1): 1-24.
  16. Petrů V, Chrobok V, Klozar J. Alergická rýma: Zásady diagnostiky a léčby Mediforum, 2. přepracované vydání, 2010, nakladatelství Maxdorf s.r.o.
  17. Brown CL, Graham SM: Nasal irrigations: good or bad?, Curr Opin otorynolaryngol Head Neck Surg, 2008; 12(1): 9-13. Go to original source... Go to PubMed...
  18. Minshall E, Ghaffar O, Cameron L, et al. Assessment by nasal biopsy of long-term use of mometasone furoate aqueous nasal spray (Nasonex) in the treatment of perennial rhinitis. Otolaryngol Head Neck Surg 1998; 118: 648-654. Go to original source...
  19. Mygind N, Nielsen LP, Hoffmann HJ, et al. Mode of action of intranasal corticosteroids. J Allergy Clin Immunol 2001; 108(Suppl. 1): S16-S2. Go to original source... Go to PubMed...
  20. Seberová E. Fluticason furoát v léčbě alergické rýmy. Farmakoterapie 2008; 3: 389-394.
  21. Fokkens WJ. Nasal corticosteroids, first choice in moderate to severe allergic rhinitis. What prevents general practitioners from using them? Allergy 2003; 58: 724-726. Go to original source... Go to PubMed...
  22. Barney NP, Graziano FM. Allergic and immunologic diseases of the eye. In: Adkinson: Middleton's Allergy: Principles and Practice. Philadelphia (PA): Mosby, 2009: 1117-1137. Go to original source...
  23. Baroody FM, Foster KA, Markaryan A, et al. Nasal ocular reflex and eye symptoms in patients with allergic rhinitis. Ann Allergy Asthma Immunol 2008; 100: 194-199. Go to original source... Go to PubMed...
  24. Krčmová I. Nazální kortikosteroidy a ovlivnění očních příznaků alergické rinitidy. Remedia 2009; 19, 1: 22-28.
  25. Daley-Yates PT, Kunka RL, Yin Y, et al. Bioavailability of fluticasone propionate and mometasone furoate aqueous nasal sprays. Eur J Clin Pharmacol 2004; 60: 265-268. Go to original source... Go to PubMed...
  26. Rybniček O. Fluticason furoát - nový intranazální kortikosteroid. Farmakoterapie 2008; 1: 19-22.
  27. Lange B, Lukat KF, Rettig K, et al. Efficacy, cost-effectiveness, and tolerability of mometasone furoate, levocabastine, and disodium cromoglycate nasal sprays in the treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol 2005; 95(3): 272-282. Go to original source... Go to PubMed...
  28. Krčmová I, Malá E. Užití solných roztoků v souběžné léčbě alergické rýmy, Alergie 2011; 1: 66-73.
  29. Rabago D, Pasic T, Zgierska A, Mundt M, Barret B, Maberry R. The efficasy of hypertonic saline nasal irrigation for chronic sinonasal symptoms, Otolaryngol Head neck Surg. 2005; 133(1): 3-8. Go to original source... Go to PubMed...
  30. Panzner P. Oralair- sublingvální tablety pro specifickou imunoterapii alergie způsobené pyly trav. Alergie 2010; (3): 207-212.
  31. Rybníček O, Seberová E, et al. Průvodce specifickou alergenovou imunoteprapií (SIT), Doporučení ČSAKI 2009, edit. ČIPA o.p.s., vyd. Tigis.




Clinical Pharmacology and Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.